Cita APA

Gupta, R., Othman, T., Chen, C., Sandhu, J., Ouyang, C., & Fakih, M. (2019). Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer. Oncologist.

Chicago Style Citation

Gupta, Rohan, Tamer Othman, Chen Chen, Jaideep Sandhu, Ching Ouyang, i Marwan Fakih. "Guardant360 Circulating Tumor DNA Assay Is Concordant With FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer." Oncologist 2019.

Cita MLA

Gupta, Rohan, et al. "Guardant360 Circulating Tumor DNA Assay Is Concordant With FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer." Oncologist 2019.